STOCK TITAN

Endo to Host Investor Call on Third-Quarter 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Endo, Inc. (OTCQX: NDOI) has announced it will release its third-quarter 2024 financial results on November 5, 2024, before the market opens. The company's senior management team will host a conference call and live webcast for investors at 8:30 a.m. ET on the same day.

Investors can participate in the call by dialing 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.), or by joining the live webcast through the provided link. Participants are advised to join 10 minutes before the scheduled start time. A replay of the webcast will be available within 24 hours on the company's investor relations website.

Endo, Inc. (OTCQX: NDOI) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il 5 novembre 2024, prima dell'apertura del mercato. Il team di gestione senior dell'azienda terrà una conference call e un webcast dal vivo per gli investitori alle 8:30 a.m. ET lo stesso giorno.

Gli investitori possono partecipare alla chiamata componendo 800-836-8184 (numero verde per Stati Uniti e Canada) o 646-357-8785 (per chiamate internazionali), oppure partecipando al webcast dal vivo tramite il link fornito. Si consiglia ai partecipanti di collegarsi 10 minuti prima dell'orario di inizio programmato. Una registrazione del webcast sarà disponibile entro 24 ore sul sito web delle relazioni con gli investitori dell'azienda.

Endo, Inc. (OTCQX: NDOI) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el 5 de noviembre de 2024, antes de la apertura del mercado. El equipo de alta dirección de la empresa llevará a cabo una conferencia telefónica y un webcast en vivo para los inversores a las 8:30 a.m. ET del mismo día.

Los inversores pueden participar en la llamada marcando el 800-836-8184 (número gratuito en EE. UU. y Canadá) o el 646-357-8785 (fuera de EE. UU.), o uniéndose al webcast en vivo a través del enlace proporcionado. Se aconseja a los participantes unirse 10 minutos antes de la hora de inicio programada. Una repetición del webcast estará disponible dentro de 24 horas en el sitio web de relaciones con inversores de la empresa.

Endo, Inc. (OTCQX: NDOI)는 2024년 3분기 재무 결과2024년 11월 5일에 시장 개장 전에 발표할 것이라고 발표했습니다. 회사의 고위 경영진은 같은 날 오전 8시 30분 ET에 투자자를 위한 컨퍼런스 콜 및 라이브 웹캐스트를 진행할 것입니다.

투자자는 800-836-8184 (미국 및 캐나다 무료 전화) 또는 646-357-8785 (미국 외부)로 전화하여 콜에 참여하거나 제공된 링크를 통해 라이브 웹캐스트에 참여할 수 있습니다. 참가자는 예정된 시작 시간보다 10분 일찍 접속하는 것이 좋습니다. 웹캐스트의 재생은 회사의 투자자 관계 웹사이트에서 24시간 이내에 제공됩니다.

Endo, Inc. (OTCQX: NDOI) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 5 novembre 2024, avant l'ouverture du marché. L'équipe de direction senior de l'entreprise organisera une conférence téléphonique et un webinaire en direct pour les investisseurs à 8h30 ET le même jour.

Les investisseurs peuvent participer à l'appel en composant le 800-836-8184 (numéro sans frais pour les États-Unis et le Canada) ou le 646-357-8785 (depuis l'extérieur des États-Unis), ou en rejoignant le webinaire en direct via le lien fourni. Les participants sont invités à se connecter 10 minutes avant l'heure de début prévue. Un enregistrement du webinaire sera disponible dans les 24 heures sur le site Web des relations avec les investisseurs de l'entreprise.

Endo, Inc. (OTCQX: NDOI) hat bekannt gegeben, dass es seine Finanzergebnisse für das dritte Quartal 2024 am 5. November 2024 vor Markteröffnung veröffentlichen wird. Das leitende Managementteam des Unternehmens wird am selben Tag um 8:30 Uhr ET einen Konferenzanruf und ein Live-Webcast für Investoren durchführen.

Investoren können an dem Anruf teilnehmen, indem sie 800-836-8184 (gebührenfrei in den USA und Kanada) oder 646-357-8785 (außerhalb der USA) wählen oder über den bereitgestellten Link am Live-Webcast teilnehmen. Den Teilnehmern wird geraten, 10 Minuten vor dem geplanten Beginn beizutreten. Eine Wiederholung des Webcasts wird innerhalb von 24 Stunden auf der Investor-Relations-Website des Unternehmens zur Verfügung stehen.

Positive
  • None.
Negative
  • None.

MALVERN, Pa., Oct. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will release its third-quarter 2024 financial results on November 5, 2024, prior to market open. Members of Endo's senior management team will host a conference call and live webcast for investors at 8:30 a.m. ET.

To participate in the call, please dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.) or join the live webcast at this link. Please join 10 minutes prior to the scheduled start time.

A replay of the webcast will be available within 24 hours at investor.endo.com.

About Endo
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-host-investor-call-on-third-quarter-2024-financial-results-302276693.html

SOURCE Endo, Inc.

FAQ

When will Endo (NDOI) release its Q3 2024 financial results?

Endo (NDOI) will release its third-quarter 2024 financial results on November 5, 2024, before the market opens.

How can investors participate in Endo's (NDOI) Q3 2024 earnings call?

Investors can participate in Endo's Q3 2024 earnings call by dialing 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.), or by joining the live webcast through the provided link.

What time is Endo's (NDOI) Q3 2024 earnings call scheduled for?

Endo's (NDOI) Q3 2024 earnings call is scheduled for 8:30 a.m. ET on November 5, 2024.

Where can investors find a replay of Endo's (NDOI) Q3 2024 earnings webcast?

A replay of Endo's (NDOI) Q3 2024 earnings webcast will be available within 24 hours at investor.endo.com.

ENDO INC

OTC:NDOI

NDOI Rankings

NDOI Latest News

NDOI Stock Data

1.80B
67.50M
57.22%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Malvern